DCOY
Decoy Therapeutics Inc.
Company Overview
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.
SectorHealthcare
IndustryBiotechnology
Market Cap$516.0K
Last DividendNone
Employees11
CEOFrederick E. Pierce
Websitehttps://decoytx.com
Valuation
Current Price$0.97
Fair Value?$000.00
Valuation?No valuation
Current PE ?0.01
Hist. PE ?N/Aⓘ
EPS (TTM) ?183.54
Forward EPS Growth ?—
Historical Growth ?48.03%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro
Price?
EPS?
Revenue?
Equity?
ProAvailable on the Pro plan
Free Cash Flow?
ProAvailable on the Pro plan
Long Term Debt?
ProAvailable on the Pro plan
Net Profit?
ProAvailable on the Pro plan
Shares Outstanding?
ProAvailable on the Pro plan
Last updated: 10/23/2026, 11:02:42 PM